The potential effect of GSTP1 polymorphism on this parameter of glycemic control, most probably through regulation of response to oxidant stress, might be useful in better selection of T2D patients who need specific pharmacological strategies focusing not only on lowering glucose, but also on oxidative stress. The gene discussed is GSTP1; the disease is type 2 diabetes mellitus.